Neurology

CIDP

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
 

Who is Impacted?

Although it can occur at any age and in both genders, CIDP is more common in young adults, and in men more so than women.
 

How is CIDP diagnosed?

CIDP is difficult to diagnose, because it is a rare disorder. Prescribers tend to rule out more common diseases prior to reaching a CIDP diagnosis.

To reach the diagnosis, several tests and exams are utilized. The prescriber will likely take a detailed medical history and ask to explain symptoms as detailed as possible, especially how it started, and whether or not they have progressed. For a CIDP diagnosis, symptoms must be experienced for a minimum of eight weeks.

Additional tests may ordered to examine other parts of the body. A nerve conduction test can determine how quickly nerve impulses move through the body. This reading can help in the future to determine if these impulses are improving or worsening.

Likewise, a spinal fluid analysis and blood or urine tests can help rule out other possible causes for experienced symptoms.
 

How is CIDP treated?

After a CIDP diagnosis has been determined, a referral will be required to see a specialist. These physicians specialize in treating autoimmune or immune-mediated disorders and have additional experience in lifestyle changes that may help slow down the progression of the disease. The goal of treatment for CIDP is to stop the attacks on the myelin to reduce the progression of symptoms.The first line of treatment are corticosteroids, specifically prednisone.

Other treatments include:

• Plasma exchange
• IVIG
• Immunosuppressants
• Stem cell transplant